The results of the staining indicated that 59.01% of the tumor tissue samples and 10.56% of adjacent tissue samples showed positive staining for MEF2A, and the staining intensity was stronger in the tumor tissues than that in adjacent tissues (Fig. 1e). The gene discussed is MEF2A; the disease is neoplasm.